Zeb1 and Snail1 engage miR-200f transcriptional and epigenetic regulation during EMT

International Journal of Cancer

Volumn 136, Issue 4, 2015, Pages E62-E73

  Díaz López, Antonio ^a   Díaz Martín, Juan ^b   Moreno Bueno, Gema ^a,c   Cuevas, Eva P ^a,d   Santos, Vanesa ^a,d   Olmeda, David ^e   Portillo, Francisco ^a   Palacios, José ^b,f   Cano, Amparo ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b UNIVERSITY OF SEVILLE   (Spain)

^c MD ANDERSON CANCER CENTER   (Spain)

^d HOSPITAL UNIVERSITARIO LA PAZ IDIPAZ   (Spain)

^e INSTITUTO DE SALUD CARLOS III   (Spain)

^f HOSPITAL RAMÓN Y CAJAL   (Spain)

Author keywords

EMT; Hypermethylation; MET; MiR 200f; Snail1; Snail2; Zeb1

Indexed keywords

MICRORNA; MICRORNA 200F; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SLUG; TRANSCRIPTION FACTOR SNAIL1; TRANSCRIPTION FACTOR ZEB1; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; MIRN200 MICRORNA, HUMAN; SNAIL FAMILY TRANSCRIPTION FACTORS; ZEB1 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; DOWN REGULATION; EMBRYO; EPIGENETIC REPRESSION; EPIGENETICS; EPITHELIAL MESENCHYMAL TRANSITION; GAIN OF FUNCTION MUTATION; GENE EXPRESSION REGULATION; GENE LOCUS; HUMAN; HUMAN CELL; LOSS OF FUNCTION MUTATION; MDCK CELL LINE; NONHUMAN; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; TRANSCRIPTION REGULATION; ANIMAL; DOG; GENETIC EPIGENESIS; GENETICS; HEK293 CELL LINE; METABOLISM; PHENOTYPE; PHYSIOLOGY;

ANIMALS; DNA METHYLATION; DOGS; EPIGENESIS, GENETIC; EPITHELIAL-MESENCHYMAL TRANSITION; GENE EXPRESSION REGULATION, NEOPLASTIC; HEK293 CELLS; HOMEODOMAIN PROTEINS; HUMANS; MADIN DARBY CANINE KIDNEY CELLS; MICRORNAS; PHENOTYPE; PROMOTER REGIONS, GENETIC; TRANSCRIPTION FACTORS;

EID: 84918843194     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.29177     Document Type: Article

References (48)

1. Yang J, Weinberg RA. Epithelial-mesenchymal transition: At the crossroads of development and tumor metastasis. Dev Cell 2008;14:818-29
2. Thiery JP, Acloque H, Huang RY, et al. Epithelial- mesenchymal transitions in development and disease. Cell 2009;139:871-90
3. Nieto MA, Cano A. The epithelial-mesenchymal transition under control: global programs to regulate epithelial plasticity. Semin Cancer Biol 2012; 22:361-8
4. Ocaña OH, Corcoles R, Fabra A, et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer Prrx1. Cancer Cell 2012;22:709-24.
5. Nieto MA. Epithelial plasticity: A common theme in embryonic and cancer cells. Science 2013;342: 1234850
6. Tsai JH, Donaher JL, Murphy DA, et al. Spatiotemporal regulation of epithelial-mesenchymal transition is essential for squamous cell carcinoma metastasis. Cancer Cell 2012;22:725-36
7. De Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013;13:97-110
8. Peinado H, Olmeda D, Cano A. Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype? Nat Rev Cancer 2007;7:415-28
9. Moreno-Bueno G, Cubillo E, Sarrio D, et al. Genetic profiling of epithelial cells expressing Ecadherin repressors reveals a distinct role for Snail, Slug, and E47 factors in epithelialmesenchymal transition. Cancer Res 2006;66: 9543-56
10. Taube JH, Herschkowitz JI, Komurov K, et al. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes. Proc Natl Acad Sci USA 2010;107: 15449-54
11. Sobrado VR, Moreno-Bueno G, Cubillo E, et al. The class I bHLH factors E2-2A and E2-2B regulate EMT. J Cell Sci 2009;122:1014-24
12. Tran DD, Corsa CA, Biswas H, et al. Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence. Mol Cancer Res 2011;9:1644-57
13. Shirakihara T, Saitoh M, Miyazono K. Differential regulation of epithelial and mesenchymal markers by deltaEF1 proteins in epithelial mesenchymal transition induced by TGF-beta. Mol Biol Cell 2007;18:3533-44
14. Cano A, Nieto MA. Non-coding RNAs take centre stage in epithelial-to-mesenchymal transition. Trends Cell Biol 2008;18:357-9
15. Castilla MA, Moreno-Bueno G, Romero-Perez L, et al. Micro-RNA signature of the epithelialmesenchymal transition in endometrial carcinosarcoma. J Pathol 2011;223:72-80
16. Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 2012;13:271-82
17. Pencheva N, Tavazoie SF. Control of metastatic progression by microRNA regulatory networks. Nat Cell Biol 2013;15:546-54
18. Brabletz S, Brabletz T. The ZEB/miR-200 feedback loop-A motor of cellular plasticity in development and cancer? EMBO Rep 2010;11:670-7
19. Burk U, Schubert J, Wellner U, et al. A reciprocal repression between ZEB1 and members of the miR-200 family promotes EMT and invasion in cancer cells. EMBO Rep 2008;9:582-9
20. Gregory PA, Bert AG, Paterson EL, et al. The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1. Nat Cell Biol 2008;10:593-601
21. Bracken CP, Gregory PA, Kolesnikoff N, et al. A double-negative feedback loop between ZEB1- SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res 2008;68:7846-54
22. Siemens H, Jackstadt R, Hunten S, et al. miR-34 and SNAIL form a double-negative feedback loop to regulate epithelial-mesenchymal transitions. Cell Cycle 2011;10:4256-71
23. Liu YN, Yin JJ, Abou-Kheir W, et al. MiR-1 and miR-200 inhibit EMT via Slug-dependent and tumorigenesis via Slug-independent mechanisms. Oncogene 2013;32:296-306
24. Brabletz T. To differentiate or not-routes towards metastasis. Nat Rev Cancer 2012;12:425-36
25. Sanchez-Tillo E, Liu Y, de Barrios O, et al. EMTactivating transcription factors in cancer: beyond EMT and tumor invasiveness. Cell Mol Life Sci 2012;69:3429-56
26. Diaz-Lopez A, Moreno-Bueno G, Cano A. Role of microRNA in epithelial to mesenchymal transition and metastasis and clinical perspectives. Cancer Manag Res 2014;6:205-16
27. Cano A, Perez-Moreno MA, Rodrigo I, et al. The transcription factor snail controls epithelialmesenchymal transitions by repressing Ecadherin expression. Nat Cell Biol 2000;2:76-83
28. Comijn J, Berx G, Vermassen P, et al. The twohanded E box binding zinc finger protein SIP1 downregulates E-cadherin and induces invasion. Mol Cell 2001;7:1267-78
29. Bolos V, Peinado H, Perez-Moreno MA, et al. The transcription factor Slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: A comparison with Snail and E47 repressors. J Cell Sci 2003;116:499-511
30. Perez-Moreno MA, Locascio A, Rodrigo I, et al. A new role for E12/E47 in the repression of Ecadherin expression and epithelial-mesenchymal transitions. J Biol Chem 2001;276:27424-31
31. Yang J, Mani SA, Donaher JL, et al. Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell 2004;117:927-39
32. Diaz-Martin J, Diaz-Lopez A, Moreno-Bueno G, et al. A core microRNA signature associated with inducers of the epithelial-to-mesenchymal transition. J Pathol 2014;232:319-29
33. Moreno-Bueno G, Peinado H, Molina P, et al. The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat Protoc 2009;4:1591-613
34. Cubillo E, Diaz-Lopez A, Cuevas EP, et al. E47 and Id1 interplay in epithelial-mesenchymal transition. PLoS One 2013;8:e59948
35. Peinado H, Ballestar E, Esteller M, et al. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004; 24:306-19
36. Gregory PA, Bracken CP, Smith E, et al. An autocrine TGF-beta/ZEB/miR-200 signaling network regulates establishment and maintenance of epithelial-mesenchymal transition. Mol Biol Cell 2011;22:1686-98
37. Olmeda D, Jorda M, Peinado H, et al. Snail silencing effectively suppresses tumour growth and invasiveness. Oncogene 2007;26:1862-74
38. Davalos V, Moutinho C, Villanueva A, et al. Dynamic epigenetic regulation of the microRNA- 200 family mediates epithelial and mesenchymal transitions in human tumorigenesis. Oncogene 2012;31:2062-74
39. Lim YY, Wright JA, Attema JL, et al. Epigenetic modulation of the miR-200 family is associated with transition to a breast cancer stem-cell-like state. J Cell Sci 2013;126:2256-66
40. Thuault S, Valcourt U, Petersen M, et al. Transforming growth factor-beta employs HMGA2 to elicit epithelial-mesenchymal transition. J Cell Biol 2006;174:175-83
41. Thuault S, Tan EJ, Peinado H, et al. HMGA2 and Smads co-regulate SNAIL1 expression during induction of epithelial-to-mesenchymal transition. J Biol Chem 2008;283:33437-46
42. Korpal M, Lee ES, Hu G, et al. The miR-200 family inhibits epithelial-mesenchymal transition and cancer cell migration by direct targeting of E-cadherin transcriptional repressors ZEB1 and ZEB2. J Biol Chem 2008;283:14910-4
43. Park SM, Gaur AB, Lengyel E, et al. The miR- 200 family determines the epithelial phenotype of cancer cells by targeting the E-cadherin repressors ZEB1 and ZEB2. Genes Dev 2008;22:894-907
44. Espada J, Peinado H, Lopez-Serra L, et al. Regulation of SNAIL1 and E-cadherin function by DNMT1 in a DNA methylation-independent context. Nucleic Acids Res 2011;39:9194-205
45. Dave N, Guaita-Esteruelas S, Gutarra S, et al. Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J Biol Chem 2011;286:12024-32
46. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, et al. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008;68:989-97
47. Lu M, Jolly MK, Levine H, et al. MicroRNAbased regulation of epithelial-hybridmesenchymal fate determination. Proc Natl Acad Sci USA 2013;110:18144-9
48. Caramel J, Papadogeorgakis E, Hill L, et al. A switch in the expression of embryonic EMTinducers drives the development of malignant melanoma. Cancer Cell 2013;24:466-80.